These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 4820523)
1. [Treatment of bone metastases of breast cancer with progestogens]. Ryckewaert A; Lemaire V Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):29-32. PubMed ID: 4820523 [TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates for cancer patients: why, how, and when? Body JJ; Mancini I Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223 [TBL] [Abstract][Full Text] [Related]
3. [Role of chemotherapy in the treatment of bone metastases of breast cancer]. Cayla J; Auclerc C; Goldberg D; Darne C; Jacquillat C Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):651-6. PubMed ID: 6523016 [TBL] [Abstract][Full Text] [Related]
4. [Anti-oestrogen treatment of metastasising carcinoma of the breast (author's transl)]. Henningsen B; Amberger H Dtsch Med Wochenschr; 1977 May; 102(19):713-6. PubMed ID: 870301 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial. Cartenì G; Bordonaro R; Giotta F; Lorusso V; Scalone S; Vinaccia V; Rondena R; Amadori D Oncologist; 2006; 11(7):841-8. PubMed ID: 16880243 [TBL] [Abstract][Full Text] [Related]
6. Norethisterone acetate in the treatment of advanced breast cancer. Earl HM; Rubens RD; Knight RK; Hayward JL Clin Oncol; 1984 Jun; 10(2):103-9. PubMed ID: 6734001 [TBL] [Abstract][Full Text] [Related]
7. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer. Kim R; Osaki A; Toge T Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161 [TBL] [Abstract][Full Text] [Related]
8. Clinical trials in metastatic breast cancer to bone: past--present--future. Body JJ Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520 [TBL] [Abstract][Full Text] [Related]
9. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases]. Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984 [TBL] [Abstract][Full Text] [Related]
11. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast. Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634 [TBL] [Abstract][Full Text] [Related]
12. Sex chromatin and hormonal treatment in breast cancer with bone metastases. Siracká E; Siracký J Neoplasma; 1969; 16(2):205-8. PubMed ID: 5822920 [No Abstract] [Full Text] [Related]
13. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy. Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071 [TBL] [Abstract][Full Text] [Related]
14. Norethisterone acetate in the treatment of advanced breast cancer. Rubens RD; Knight RK; Hayward JL Eur J Cancer (1965); 1976 Jul; 12(7):563-5. PubMed ID: 954799 [No Abstract] [Full Text] [Related]
15. Treatment of advanced and relapsing breast cancer with a combination of paclitaxel and mitoxantrone. South-Central Hellenic Oncology Group. Panagos GE Semin Oncol; 1997 Feb; 24(1 Suppl 3):S17-21. PubMed ID: 9071335 [TBL] [Abstract][Full Text] [Related]
16. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases]. Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740 [TBL] [Abstract][Full Text] [Related]
17. [Hypercalcemia in breast cancer]. Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868 [TBL] [Abstract][Full Text] [Related]
18. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases. Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528 [TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896 [TBL] [Abstract][Full Text] [Related]
20. [Oral gestagen treatment of advanced breast neoplasms with norethisterone acetate]. Varini M; Tancini G; Mauri M; Bonadonna G Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1070-3. PubMed ID: 7423152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]